Clinical Trial Update: Effect of Melatonin and Metformin on Glycemic Control Genotoxicity and Cytotoxicity Markers in Patients With Prediabetes [Phase 2]

View source ↗

Summary

Phase 2 trial exploring melatonin and metformin effects on glycemic control and biological toxicity markers in prediabetes patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• Melatonin (melatonin)
• metformin (metformin)

Snippet

Sponsor: University of Guadalajara | Conditions: PreDiabetes | Phase 2 | Status: UNKNOWN